Member Info for PM2022

Interesting last hour to come. Could we see some panic buying before close leading into Monday if news is coming.

30-35p close would be great.

Forget the small targets. A deal lands we will be looking at1st Target = 135p

2nd Target = 248p

3rd Target = 373p

Think big and aim high. A deal for 201 will be transformational and will attract massive interest.

Not with a deal I am afraid. Gotta be daft to sell at 50p with a deal.

With milestone of 100s millions and possible deal for 301 on the way as well 50p is very low. I will sell a few at 80p or 100p and keep most as I think potential is massive if you are happy to wait. Rather invest here than go elsewhere and lose money.

More than anything looking forward to seeing what the milestone payments will be for 201.

No doubt will generate massive interest among new investors. I can see this hitting £1 after a deal.

Porky is it you buying all these shares today?

Why does this have a feel a deal early next week. Exciting times.

They not letting it drop this time. We all know it is due and it is almost late Sept.

Could well be a final call for those that do not want to miss a nice big gap up on open. Forget the pennies this is not worth missing.

Better than paying 80p plus after the first deal with all the milestones attached.

Market cap still only 16 million needs to go a long way ahead with all the clinical drugs we have and deals that are imminent. It's Friday so expect a decent rise going into Monday.

Porky thank you. Can you ask her if she will be sharing details of the work done with PYC through an RNS and the potential for treatment for Sepsis and Coronavirus or other cancers through this work and that the project does not need an extension and should shortly be finished. Also any positive findings regarding 201 with the work done by PYC that would increase the value of the drug?

It's clear we are reaching a point where a deal has to come or a placing and it has already been stated we will not get a placing. I stick with my September prediction for a deal for 201 and possibly next week before the meeting would make sense.

I am interested to see what the next few days bring. Looks like they were holding back on the new pipeline until funding was confirmed.

Could we see an RNS come tomorrow or early next week regarding a deal for 201 which is very much due.

And deservedly so. New potential treatment for breast cancer.

Three big deals possible very soon with 201 being very likely soon. Market cap only 15 million. 65 million shares only. It really does not get better.

Hoping for 30p close of play. Keep going. Great news.

Suzy pushing news through before the meeting. Could well get the big 201 deal that is due in the next few days.

No doubt will have lots to talk about if the deal comes and new pipeline.

Huge RNS for 201 due any week now. 301 and 401 could also have a deal anytime before end of the year.

New pipeline and market cap only 14 million. Cenkos have a free ride from 22p so all positive and a great buy.

Would make sense to release this RNS first before the big deal next week so people don't exit as much after the deal.

How can they speak about development without cash and most of it would be sensitive information unless a deal is finalised before.

Perhaps next week will be the big week or at least an update of some sort before a deal.

Could be last push before transformational RNS.

They need to give time for questions to come in so maybe RNS tomorrow or Thursday.

They are looking at growth and development. That can only realistically happen with a deal and he will likely discuss growth therefore you need a deal to do this.

It looks like it is finally happening and deal should be imminent in the next 2 weeks. Lots of buys as well so all clear.

Now I am sure they want to talk about positive news and will want new questions submitted regarding the deal. So hopefully RNS regarding deal in the next 2 weeks. Hopefully nice rise during the month leading to a transformational deal.

ValiRx plc is pleased to announce that Suzanne Dilly (CEO), Dr Kevin Cox (Non-Executive Chairman) and Mark Treharne (Corporate Development Manger) will provide a live Investor update presentation via the Investor Meet Company platform on 28th Sep 2021 at 1:00pm BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Basic research Rahel if you watched her most recent interview and read all her Q and As. No placing planned therefore where do people think she will get the money from given cash will run out early next year. Also everything she has said has been positive regarding 201 discussions therefore I know she will get a deal.

No comment in regards to how good the deal will be but regardless our market cap is very low so we should see a significant rise if we get any deal.